CLINICAL_TRIALS
trial_result
· 2009-06-23
Clinical Trial Update: Phase II Study of ZD6474 in Advanced NSCLC [Phase 2]
Summary
Phase II study of vandetanib (ZD6474) in advanced non-small cell lung cancer was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2009-06-23